Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
NECO / NECA Phase II, Open label Study of the Poly(ADP-ribose) Polymerase Inhibitor Niraparib (MK 4827) in Recurrent Endometrial CancerJimenez, Dr WaldoOpenNCT03016338
FORWARD 1FORWARD 1: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab soravtansine (IMGN853) Versus Investigator’s Choice of Chemotherapy in Women with Folate Receptor α−positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube CancerHirte, Dr HalOpenNCT02631876
PHL-086A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial CancerHirte, Dr HalOn holdNCT01815151
Download PDF